Prevalence and treatment of menopausal symptoms among breast cancer survivors (Q44030200)

29 November 2017

Prevalence and treatment of menopausal symptoms among breast cancer survivors (English)

1 reference

29 November 2017

5

Polly A Newcomb

1 reference

29 November 2017

Patricia F Harris

1

1 reference

29 November 2017

Patrick L Remington

series ordinal

2

1 reference

29 November 2017

Amy Trentham-Dietz

series ordinal

3

1 reference

29 November 2017

Catherine I Allen

series ordinal

4

1 reference

29 November 2017

1 June 2002

1 reference

Journal of Pain and Symptom Management

29 November 2017

1 reference

29 November 2017

23

1 reference

29 November 2017

501-509

1 reference

29 November 2017

6

1 reference

Risk of menopause during the first year after breast cancer diagnosis

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

The risk of premature menopause induced by chemotherapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

The consensus conference on treatment of estrogen deficiency symptoms in women surviving breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Symptoms associated with tamoxifen treatment in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Breast cancer survivors: psychosocial concerns and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Megestrol Acetate for the Prevention of Hot Flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Transdermal clonidine for ameliorating tamoxifen-induced hot flashes

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

A review of the incorporation of complementary and alternative medicine by mainstream physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Why patients use alternative medicine: results of a national study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Use of alternative medicine by women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Use of alternative medicine by women with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

The use of complementary therapies by breast cancer patients attending conventional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Association between use of unconventional therapies and conventional medical services

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Unconventional medicine in the United States. Prevalence, costs, and patterns of use

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Use of alternative medicine--a marker for distress?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Alternative therapies used by women with breast cancer in four ethnic populations

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Use of alternative therapies: estimates from the 1994 Robert Wood Johnson Foundation National Access to Care Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Lactation in relation to postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

A randomised phase III cross-over study of tamoxifen versus megestrol acetate in advanced and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Hormone replacement therapy in breast cancer survivors: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

A case-control study of hormone replacement therapy after primary surgical breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Estrogen deficiency: In search of symptom control and sexuality.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Historical background of clinical trials involving women and minorities

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

Recruiting minorities into clinical trials: toward a participant-friendly system

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900395-0

7 January 2021

10.1016/S0885-3924(02)00395-0

Identifiers

DOI

1 reference

29 November 2017

1 reference